Richard Martin
Exelixis (United States)(US)
Publications by Year
Research Areas
Cholesterol and Lipid Metabolism, Drug Transport and Resistance Mechanisms, Peroxisome Proliferator-Activated Receptors, Estrogen and related hormone effects, Advancements in Transdermal Drug Delivery
Most-Cited Works
- → Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand(2004)193 cited
- → Identification of a Selective Inverse Agonist for the Orphan Nuclear Receptor Estrogen-Related Receptor α(2004)169 cited
- → Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)(2009)161 cited
- → Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils(2016)158 cited
- → Transdermal and transbuccal drug delivery systems: Enhancement using iontophoretic and chemical approaches(2011)44 cited
- → Liver X Receptor (LXR) partial agonists: Biaryl pyrazoles and imidazoles displaying a preference for LXRβ(2014)42 cited
- → Pharmacological Characterization of a Novel Liver X Receptor Agonist with Partial LXRα Activity and a Favorable Window in Nonhuman Primates(2014)40 cited
- → Discovery of Highly Potent Liver X Receptor β Agonists(2016)33 cited
- → Enhanced in vitro transbuccal drug delivery of ondansetron HCl(2010)28 cited
- → FXR, A Therapeutic Target for Bile Acid and Lipid Disorders(2005)24 cited